Serum IL-23 levels in patients with vitiligo

---

Copy For Citation

Cengiz F. P., Emiroglu N., CEMIL B. C., ERDEM U. G. B., KEMERIZ F.

TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY, vol.48, no.4, pp.204-207, 2014 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 48 Issue: 4
• Publication Date: 2014
• Doi Number: 10.4274/turkderm.82957
• Journal Name: TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.204-207
• Bezmialem Vakıf University Affiliated: No

Abstract

Background and Design: Interleukin-23 (IL-23) is a cytokine which is believed to have an important role in the pathogenesis of autoimmune diseases. Therefore, it can be used as a target molecule in the treatment of autoimmune diseases. The aim of our study was to determine serum IL-23 levels in patients with vitiligo to understand their possible roles in the disease etiology and to compare the results with the healthy controls.